KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Short term Debt: 2009-2011

Historic Short term Debt for Acadia Pharmaceuticals (ACAD) over the last 3 years, with Dec 2011 value amounting to $32,000.

  • Acadia Pharmaceuticals' Short term Debt fell 50.00% to $22,000 in Q1 2012 from the same period last year, while for Mar 2012 it was $22,000, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $32,000 for FY2011, which is 58.97% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Short term Debt of $32,000 as of FY2011, which was down 58.97% from $78,000 recorded in FY2010.
  • Acadia Pharmaceuticals' 5-year Short term Debt high stood at $365,000 for FY2009, and its period low was $32,000 during FY2011.
  • Moreover, its 3-year median value for Short term Debt was $78,000 (2010), whereas its average is $158,333.
  • Data for Acadia Pharmaceuticals' Short term Debt shows a maximum YoY slumped of 78.63% (in 2010) over the last 5 years.
  • Yearly analysis of 3 years shows Acadia Pharmaceuticals' Short term Debt stood at $365,000 in 2009, then plummeted by 78.63% to $78,000 in 2010, then tumbled by 58.97% to $32,000 in 2011.